Debate: How Should We Treat Geographic Atrophy

Related

• 

  Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of the Phase 3 Trials

  Paul Hahn, MD, PhD, FASRS

  Annual Meeting Talks

  2023

• 

  Utility of Outer Retinal Tubulation in Predicting Lesion Growth in Subfoveal and Nonsubfoveal Geographic Atrophy

  Srinivas Sai A Kondapalli, MD

  Annual Meeting Talks

  2023

• 

  Expert Panel: Socioeconomics

  Linda A. Lam, MD, MBA, FASRS

  Ella H Leung, MD

  Mohsin H. Ali, MD

  Hasenin Al-khersan, MD

  Miguel A. Busquets, MD, FACS

  Annual Meeting Talks

  2024